Observational analysis explores ChatGPT-4's potential to enhance clinical decision-making in pancreatic cancer, suggesting promising applications for AI in healthcare.
Introduction: With the advent of large language models, which are trained on extensive data sets of human-generated texts, different studies have demonstrated AI to be a useful tool in clinical-decision making. Since its launch in March 2024 ChatGPT-4 (OpenAI), has demonstrated superior capabilities compared to its predecessors. Whether ChatGPT-4 can assist clinical decision-making in patients with pancreatic cancer remains to be determined.
No takes yet. Share an insight, caveat, or question.
Gehrisch et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: